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vs. XRT as primary treatments in the management of 
endotracheal or endobronchial obstruction by lung 
cancer. A number of endobronchial techniques are 
now available, including laser vaporization (now 
more usually undertaken with Nd YAG laser for the 
reasons given by the authors), brachytherapy, and 
cryotherapy. XRT has the advantages that it is easy 
to apply, requires no anaesthetic, and can be used to 
treat a comparatively large tumour volume, so that 
its beneficial effects are likely to last longer than those 
of more localized treatments. Its main disadvantages 
are that it may cause temporary oesophagitis and 
cannot be used repeatedly. Brachytherapy can be 
used repeatedly, and its effects might be expected to 
last longer than those of laser therapy because clear- 
ance with laser is confined to within the tracheal or 
bronchial lumen. It can be delivered under local 
anaesthetic, but requires the availability of a 
radiation-protected theatre. Laser can be used 
repeatedly, but usually requires general anaesthetic. 
Cryotherapy requires general anaesthetic and not 
infrequently has to be given in two or three 
applications. 
The advantages and disadvantages of these tech- 
niques in comparison with those of XRT can only 
be reliably assessed in a randomized trial. Such a trial 
is now being conducted by the Medical Research 
Council Lung Cancer Working Party (protocol 
LU18). We would therefore urge clinicians with these 
treatments available, either locally or through refer- 
ral, to consider collaborating in this trial. Protocols 
and other information can be obtained from the 
MRC Cancer Trials Office. 
D. J. GIRLING AND K. MOGHISSI 
MRC Cancer Trials OfJe 
5 Shaftesbury Road, Cambridge 
and 
Goole and District Hospital 
North Humberside, U.K. 
28 November 1994 
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Dear Editor 
Smoking should be banned on health premises 
in the U.K. 
The link between tobacco smoking and ill-health is 
well recognized. However, the Health Authorities 
and Trusts, the health ‘guardians’ of the nation, are 
unable or unwilling to stop smoking completely on 
their premises. This attitude should change. Smoking 
should be banned on all health premises in the U.K. 
It is surprising and ironic that, to date, smoking is 
allowed on health premises in the U.K. In the U.S.A., 
a number of hospitals have imposed total smoking 
bans (l-3). There is overwhelming evidence of serious 
smoking-related diseases that inflict tobacco and 
passive smokers. These diseases and the premature 
deaths that they cause are preventable if only the 
afflicted did not smoke or were not exposed to 
tobacco smoke. Smoking kills 12 people every hour 
(nearly 300 people each day) in the U.K., at a cost 
to hospitals of 5437 m each year (4). If a jumbo 
jet carrying 300 passengers and crew were to crash, 
losing all these lives everyday of the year, there would 
be an ardent attempt to find out the causes of the 
accidents and stop them happening, in order to save 
lives. In spite of the number of lives being lost daily 
due to smoking-related diseases, serious and decisive 
efforts are not being made by health authorities to 
avert the carnage caused by smoking tobacco. 
The NHS Health Authorities, NHS Trusts and 
private health companies have moral and statutory 
responsibilities to provide health care and health 
promotion. Therefore, Health Authorities, Trusts 
and others ought to ban smoking on all their pre- 
mises to help this cause. Smoking bans should be 
imposed in all hospitals in the U.K. In some hospi- 
tals, ‘No Smoking’ signs and notices are clearly 
marked or displayed but are ignored by some 
smokers: staff, patients and visitors alike. Besides 
hospitals, smoking should be banned on all premises 
of general practice surgeries, health centres and day 
hospitals. Indeed, Health Authority and NHS Trust 
offices should also be no-smoking premises. 
A considerable number of psychiatric patients 
are smokers. Hence psychiatric units face immense 
problems banning smoking on such premises, as 
some of these patients, by the nature of their illnesses, 
lack insight and may be unto-operative. However, 
this should not prevent the ban from being imposed, 
even on these premises. 
There are hospitals which claim to be non-smoking 
but are not rigorous enough to keep them non- 
smoking. Currently on some health premises, where 
smoking is permitted, it is limited to certain well- 
defined areas (5). Tobacco smoke can drift from 
designated smoking areas to areas where unintended. 
Providing smoking places may be an indirect or a 
tacit message to smokers that smoking is allowed, 
maintained, or even endorsed on the premises. 
Accordingly, designated smoking areas should not be 
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provided. In July 1992, the British Government of 
the day launched The Health of The Nation, setting 
out objectives and targets to achieve the reduc- 
tion of tobacco consumption in all age groups, in 
order to reduce smoking-related diseases by the year 
2000 (6). 
Despite convincing, available evidence that a ban 
on tobacco advertising would substantially reduce its 
consumption (7), the same Government only suggests 
that tobacco companies regulate their own advertis- 
ing, and is unwilling to totally ban advertising and 
promotion of tobacco products in the U.K. (8). The 
Government increases to price of tobacco leads to a 
minimal reduction in smoking, which is far from 
enough to make a significant number of smokers stop 
the habit. Her Majesty’s Treasury makes &9 bn each 
year from tax on tobacco products. The misery of 
smoking-related diseases, the number of working 
days lost to industries when employees go off sick 
and the cost to the NHS, put together, will equal or 
exceed the tax that the Treasury gets. 
Health Authorities and Health Trusts can totally 
ban smoking and the sale of tobacco products on 
their health premises. Libertarians may criticize this, 
but it is medical logic to do so. 
There has been a recent idea that people who 
persist in unhealthy habits such as smoking, heavy 
drinking and over-eating are likely to be abandoned 
by the NHS as resources are targeted on ‘low-risk’ 
patients (9). Until this idea becomes reality, smokers 
who ask for help to give up smoking or the use of 
tobacco products should be actively encouraged, 
supported and, if necessary, treated under the NHS 
to maximize positive results. 
Smokers can be fore-warned, for instance, 12-18 
months, that smoking will be banned on all health 
premises. The ban can then be imposed, for example, 
with effect from the National No Smoking Day. 
When this is implemented, the health of the nation 
would have moved a step forward in the right 
direction. 
M. L. KAYENTE 
The Queen Elizabeth Psychiatric Hospital 
Queen Elizabeth Medical Centre 
Edgbaston 
Birmingham B15 2QZ, U.K. 
30 November 1994 
References 
1. Hurt RD, Berge KG, Offord KP ef al. The making of a 
smoke-free medical center. JAMA 1989; 261: 95-97. 
2. Stillman FA, Becker DM, Swank RT ef al. Ending 
smoking at the Johns Hopkins medical institutions. 
JAMA 1990; 264: 1565-1569. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
Orleans CD, Slade J. Smoking ban in US hospitals 
presents new challenges. Tobacco Control 1992; 1: 
4647. 
The Independent Television News. Health Education 
Authority Report: Smoking kills twelve every hour. 
Oracle 114, Monday 12 October 1992, 13:45:00. 
Department of Health and Social Security. Promoting 
Non-Smoking on NHS Premises. London: DHSS, 1985. 
HC(85)22-HCFP(85)13. 
Department of Health White Paper. The Health of The 
Nation. London: HMSO, 1991. 
Editorial - Department of Health reports on tobacco 
advertising - A ban would significantly cut consumption. 
BMJ 1992; 305: 111~1111. 
Taylor R. EC ministers split on tobacco advertising. 
BMJ 1992; 305: 1247. 
Jones J. Health Correspondent, ‘NHS set to abandon 
drinkers, smokers’, The Observer, Sunday 7 November 
1993; No. 10543, p. 1. 
Dear Editor 
Superior vena cava obstruction in a patient with 
cystic fibrosis and a long-term indwelling catheter 
We were interested to read the report by Peckham 
et al. (1) describing resolution of superior vena cava 
obstruction in a patient with cystic fibrosis and a 
long-term indwelling catheter. 
In 1992,6 yr after having a Port-A-Cath indwelling 
access device sited in the right upper chest, a 22-year- 
old female with cystic fibrosis presented with a weeks 
history of her right arm becoming ‘dead’, blue and 
swollen when she exercised with weights at the gym. 
After 30 min rest the signs resolved. She also had 
pain down the right arm with swimming. Towards 
the end of the week, any use of the arm led to aching. 
On examination, her right arm was swollen with 
dilated veins. A right upper limb venogram showed 
an irregular filling defect at the site of entry of the 
Port-A-Cath catheter in the proximal subclavian 
vein. There was no area of stenosis in our patient and 
the appearance suggested a thrombus. She was 
referred for angioplasty and thrombolysis. Cannu- 
lation of the right antecubital vein failed and there- 
fore the right femoral vein was used and the 
subclavian dilated to 8 mm using 2 balloons. She also 
received a slow infusion of 35 international units of 
TPA given over a period of 2 h, and an overnight 
infusion of 15 units of TPA given over a period of 
12 h, in addition to 500 international units of heparin 
h - ‘. The following morning on the repeat venogram 
there was no residual thrombus. However, there was 
some recoil of the previously dilated aspect of the 
vein. This was redilated to 8 mm and the patient was 
commenced on warfarin. Her symptoms resolved. A 
repeat caval venogram 6 months following showed 
